文献速递新发突发、热带与寄生虫病

大湄公河次区域抗疟药耐药分子流行病学:一项观察性研究

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study.
PubMed 文献 · Lancet Infect Dis · 2020-07-14

结果显示青蒿素耐药pfkelch Cys580Tyr单倍型(PfPailin)在东部次区域占主导,并出现哌喹耐药相关pfplasmepsin2扩增和pfcrt突变;缅甸存在青蒿素耐药pfkelch Phe446Ile单倍型广泛传播,但未发现ACT伴侣药耐药标记选择。

要点

  • 青蒿素耐药PfPailin谱系在东部大湄公河次区域占主导。
  • 缅甸广泛传播青蒿素耐药pfkelch Phe446Ile单倍型。
  • 缅甸未发现ACT伴侣药耐药标记的选择和由东向西传播证据。

核心结论

  • 恶性疟原虫青蒿素耐药在大湄公河次区域已普遍存在。
  • 东部次区域以多重耐药PfPailin谱系为主,缅甸存在青蒿素耐药单倍型广泛传播但无ACT伴侣药耐药基因型证据。

主要发现

  • 与哌喹耐药相关的pfplasmepsin2基因扩增及pfcrt Lys76Thr下游突变已出现。
  • 泰国-缅甸边境另一pfkelch Cys580Tyr谱系在消除前频率升高,缅甸其他地区Cys580Tyr等位基因广泛存在但频率低。
  • 单个青蒿素耐药pfkelch Phe446Ile单倍型在缅甸广泛传播。
  • 缅甸克伦邦大量使用双氢青蒿素-哌喹(治疗和 масс药物给药)未观察到哌喹耐药标记选择,pfmdr1扩增(甲氟喹耐药标记)全区域低流行。

临床怎么用

  • 在东部大湄公河次区域需应对以PfPailin为主的多重耐药恶性疟原虫谱系。
  • 缅甸青蒿素耐药广泛但基因分型未提示ACT伴侣药耐药,仍有机会阻止ACT耐药全球传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Greater Mekong subregion is a recurrent source of antimalarial drug resistance in Plasmodium falciparum malaria. This study aimed to characterise the extent and spread of resistance across this entire region between 2007 and 2018. METHODS: P falciparum isolates from Myanmar, Thailand, Laos, and Cambodia were obtained from clinical trials and epidemiological studies done between Jan 1, 2007, and Dec 31, 2018, and were genotyped for molecular markers (pfkelch, pfcrt, pfplasmepsin2, and pfmdr1) of antimalarial drug resistance. Genetic relatedness was assessed using microsatellite and single nucleotide polymorphism typing of flanking sequences around target genes. FINDINGS: 10 632 isolates were genotyped. A single long pfkelch Cys580Tyr haplotype (from -50 kb to +31·5 kb) conferring artemisinin resistance (PfPailin) now dominates across the eastern Greater Mekong subregion. Piperaquine resistance associated with pfplasmepsin2 gene amplification and mutations in pfcrt downstream of the Lys76Thr chloroquine resistance locus has also developed. On the Thailand-Myanmar border a different pfkelch Cys580Tyr lineage rose to high frequencies before it was eliminated. Elsewhere in Myanmar the Cys580Tyr allele remains widespread at low allele frequencies. Meanwhile a single artemisinin-resistant pfkelch Phe446Ile haplotype has spread across Myanmar. Despite intense use of dihydroartemisinin-piperaquine in Kayin state, eastern Myanmar, both in treatment and mass drug administrations, no selection of piperaquine resistance markers was observed. pfmdr1 amplification, a marker of resistance to mefloquine, remains at low prevalence across the entire region. INTERPRETATION: Artemisinin resistance in P falciparum is now prevalent across the Greater Mekong subregion. In the eastern Greater Mekong subregion a multidrug resistant P falciparum lineage (PfPailin) dominates. In Myanmar a long pfkelch Phe446Ile haplotype has spread widely but, by contrast with the eastern Greater Mekong subregion, there is no indication of artemisinin combination therapy (ACT) partner drug resistance from genotyping known markers, and no evidence of spread of ACT resistant P falciparum from the east to the west. There is still a window of opportunity to prevent global spread of ACT resistance. FUNDING: Thailand Science Research and Innovation, Initiative 5%, Expertise France, Wellcome Trust.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Imwong M, Dhorda M, Myo Tun K, et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect Dis. 2020. PMID: 32679084. doi:10.1016/S1473-3099(20)30228-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。